Clinical trial · Interventional
Study Comparing the Efficacy of Peripherally Inserted Central Catheter (PICC) Placement With the Addition of Cyanoacrylate Glue Versus PICC Placement Alone in Patients With Cancer.
Randomized, Prospective, Single-center Trial Comparing the Efficacy of Peripherally Inserted Central Catheter (PICC) Placement With the Addition of Cyanoacrylate Glue Versus PICC Placement Alone (Without Glue) in Patients With Cancer.
NCT05944900CI-TRIAL-00081151PICCandGLUEcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a randomized, prospective, single-center trial comparing the efficacy of peripherally inserted central catheter (PICC) with the addition of cyanoacrylate glue versus PICC placement alone (without glue) in cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cyanoacrylate glue application | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- PICC placement according to standard practice + cyanoacrylate glue
- description
- PICC placement will be performed according to standard practice (Safe Insertion of PICC protocol (SIP2) steps). The catheter will be secured by the Statlock system. Cyanoacrylate glue will be applied on the catheter exit point in accordance with the instructions for use. A transparent dressing will be applied, with a compress in the event of bleeding.
- interventionNames
- Procedure: Cyanoacrylate glue application
- type
- NO_INTERVENTION
- label
- PICC placement according to standard practice
- description
- PICC placement will be performed according to standard practice (Safe Insertion of PICC protocol (SIP2) steps). The catheter will be secured by the Statlock system. A transparent dressing will be applied, with a compress in the event of bleeding.
Primary outcomes (1)
- measure
- Rate of patients with successful PICC placement
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female, 18 years of age or older on the date of signature the informed consent form * Patient with a histological diagnosis of cancer * Indication for central line chemotherapy or immunotherapy * Placement of a single-lumen PICC in the non-tunneled upper limb planned on an ambulatory basis at the Centre * Planned duration of PICC use \> 30 days * Dated and signed informed consent, indicating that the patient has been informed of all relevant aspects of the study prior to inclusion; * Patient covered by a health insurance plan Exclusion Criteria: * Patient already included in the study ; * Patient with known allergy to cyanoacrylates, Violet D\&C or formaldehyde; * Patient not reachable by telephone ; * Patient under guardianship; * Patient does not speak French.
References
Publications (0)
Data not yet available
No reference posted for this study.